These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
10. Bendamustine plus Rituximab Versus R-CHOP as First-Line Treatment for Patients with Follicular Lymphoma Grade 3A: Evidence from a Multicenter, Retrospective Study. Mondello P; Steiner N; Willenbacher W; Cerchione C; Nappi D; Mauro E; Ferrero S; Cuzzocrea S; Mian M Oncologist; 2018 Apr; 23(4):454-460. PubMed ID: 29317554 [TBL] [Abstract][Full Text] [Related]
11. Cost-Effectiveness Analysis of Bendamustine Plus Rituximab as a First-Line Treatment for Patients with Follicular Lymphoma in Spain. Sabater E; López-Guillermo A; Rueda A; Salar A; Oyagüez I; Collar JM Appl Health Econ Health Policy; 2016 Aug; 14(4):465-477. PubMed ID: 27090915 [TBL] [Abstract][Full Text] [Related]
13. Is There a Best Initial Treatment for a New Patient With Low Grade Follicular Lymphoma. Jacobson CA; Freedman AS Curr Hematol Malig Rep; 2016 Jun; 11(3):218-23. PubMed ID: 26995595 [TBL] [Abstract][Full Text] [Related]
14. High-dose therapy with autologous stem cell transplantation versus chemotherapy or immuno-chemotherapy for follicular lymphoma in adults. Schaaf M; Reiser M; Borchmann P; Engert A; Skoetz N Cochrane Database Syst Rev; 2012 Jan; 1():CD007678. PubMed ID: 22258971 [TBL] [Abstract][Full Text] [Related]
15. Treatment of follicular lymphoma: current status. Tilly H; Zelenetz A Leuk Lymphoma; 2008; 49 Suppl 1():7-17. PubMed ID: 18821428 [TBL] [Abstract][Full Text] [Related]
16. Prognostic significance of histologic grade and Ki-67 proliferation index in follicular lymphoma. Xue T; Yu BH; Yan WH; Jiang XN; Tian T; Zhou XY; Li XQ Hematol Oncol; 2020 Dec; 38(5):665-672. PubMed ID: 32627854 [TBL] [Abstract][Full Text] [Related]
17. The role of obinutuzumab in the management of follicular lymphoma. O'Nions J; Townsend W Future Oncol; 2019 Nov; 15(31):3565-3578. PubMed ID: 31538821 [TBL] [Abstract][Full Text] [Related]
18. A retrospective study on the management of patients with rituximab refractory follicular lymphoma. Solal-Céligny P; Leconte P; Bardet A; Hernandez J; Troussard X Br J Haematol; 2018 Jan; 180(2):217-223. PubMed ID: 29230799 [TBL] [Abstract][Full Text] [Related]
19. Treatment of Histologic Transformation. Casulo C Hematol Oncol Clin North Am; 2020 Aug; 34(4):785-794. PubMed ID: 32586581 [TBL] [Abstract][Full Text] [Related]